A combined genotype of KIR3DL1 high expressing alleles and HLA-B*57 is associated with a reduced risk of HIV infection
- 31 July 2008
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in AIDS
- Vol. 22 (12), 1487-1491
- https://doi.org/10.1097/qad.0b013e3282ffde7e
Abstract
Objectives: Coexpression of certain combinations of natural killer cell receptor KIR3DL1 and HLA-B alleles is associated with slower time to AIDS. The strongest protection in terms of disease outcome in KIR3DL1 homozygotes (3DL1 hmz) is coexpression of HLA-B*57 and a set of KIR3DL1 genotypes (3DL1*h/*y) lacking alleles expressed at low levels on natural killer cells. We questioned whether this allele combination could also influence resistance to infection. Design: The genetic distribution of 3DL1*h/*y and HLA-B*57 was compared in 41 HIV-exposed uninfected and 186 recently HIV-infected 3DL1 hmz. Methods: KIR3DL1 subtyping was performed by sequencing the exons 3, 4, 5, 7–9. The major histocompatibility complex class IB locus was typed by sequence specific oligonucleotide PCR and sequencing to resolve Bw4 and Bw6 alleles and the amino acid present at position 80. Results: Percentage carriers of HLA-B*57 in HIV-exposed uninfected and individuals in a primary infection cohort was 12.2 and 4.3%, respectively (P = 0.0631), whereas that of 3DL1*h/*y was similar in both populations (P = 0.221). The 3DL1*h/*y-HLA-B*57 combined genotype was more frequent in exposed uninfected individuals (12.2%) than individuals in primary infection (2.7%) (P = 0.019; odds ratio, 5.03; 95% confidence intervals, 1.38–18.3). Conclusion: Coexpression of 3DL1*h/*y and B*57, which has been associated with a reduced risk of progressing to AIDS in HIV-infected individuals also lowers the risk of HIV infection in exposed uninfected individuals.Keywords
This publication has 24 references indexed in Scilit:
- Detection of KIR3DS1 on the Cell Surface of Peripheral Blood NK Cells Facilitates Identification of a Novel Null Allele and Assessment of KIR3DS1 Expression during HIV-1 InfectionPublished by The American Association of Immunologists ,2007
- Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1Nature Genetics, 2007
- Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector functionThe Journal of Experimental Medicine, 2006
- KIR3DL1 Polymorphisms That Affect NK Cell Inhibition by HLA-Bw4 LigandPublished by The American Association of Immunologists ,2005
- NK CELL RECOGNITIONAnnual Review of Immunology, 2005
- Immunogenetics of killer cell immunoglobulin-like receptorsMolecular Immunology, 2004
- Cutting Edge: Increased NK Cell Activity in HIV-1-Exposed but Uninfected Vietnamese Intravascular Drug UsersPublished by The American Association of Immunologists ,2003
- Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDSNature Genetics, 2002
- Natural killer cells, viruses and cancerNature Reviews Immunology, 2001
- Different NK Cell Surface Phenotypes Defined by the DX9 Antibody Are Due toKIR3DL1Gene PolymorphismThe Journal of Immunology, 2001